← All trials
NCT05243017
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 7, 2021
- Primary completion
- Mar 31, 2027
- Completion date
- Oct 7, 2027
- First posted
- Feb 16, 2022
- Last posted
- Sep 14, 2022
- Enrollment
- 15
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- UniQure N.V.Lead sponsor
- UniQure N.V.Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.